At the European Association for Cancer Research (EACR) Congress 2026, BioVendor will showcase molecular diagnostics solutions across PCR and NGS technologies.
The EACR 2026 Congress is a four-day international meeting dedicated to basic, preclinical, and translational cancer research. It brings together the cancer research community to share the latest findings, inspire innovation, and build knowledge, connections, and collaborations across a wide range of oncology topics. Together with the accompanying exhibition, the congress provides a platform for scientific exchange and the presentation of advanced diagnostic technologies.
Date: June 8–11, 2026
Venue: Budapest, Hungary
Booth: 61
Website: https://www.eacr.org/congress/
Contact: Iveta Tóthová, tothova@biovendor-mdx.com
BioVendor will take part in the congress at booth no. 61, where we will present our molecular diagnostics portfolio designed to support modern laboratory workflows.
BioVendor advances molecular diagnostics from PCR to high-precision NGS, connecting wet lab workflows with data insight powered by GENOVESA bioinformatics software. Our portfolio includes RealFast® for qPCR, StripAssay® for reverse hybridization, and fastGEN® and epicGEN® for NGS. These solutions support oncology, pharmacogenetics, genetic disorders, predisposition testing, and microbiome research for clinical and research laboratories.
Visitors are welcome to meet our team, explore how our technologies can be implemented into routine diagnostic workflows, and schedule a meeting with us.
We look forward to meeting you in Budapest.